# Intervention - Distance Threshold 0.4\n\nExperiment: threshold_0.4_mechanisms\nTotal clusters: 436\nSingleton clusters: 280 (64.2%)\nSilhouette score: 0.217\nDavies-Bouldin score: 1.221\n\n================================================================================\n\n## Cluster 137: immune checkpoint inhibitors\n\n**Category**: biologics\n**Members**: 9\n\n- Cemiplimab\n- bevacizumab\n- cemiplimab monotherapy\n- cemiplimab+CT combination therapy\n- immune checkpoint inhibitors\n- nivolumab monotherapy\n- pembrolizumab\n- pembrolizumab monotherapy\n- pembrolizumab+CT combination therapy\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 125: virtual reality-based cognitive rehabilitation\n\n**Category**: therapy\n**Members**: 7\n\n- Cognitive Rehabilitation Nursing\n- computerized cognitive rehabilitation\n- game-based cognitive rehabilitation\n- individualized cognitive rehabilitation\n- non-immersive virtual reality\n- second-generation virtual reality intervention\n- virtual reality-based cognitive rehabilitation\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 15: Potassium-competitive acid blockers\n\n**Category**: medication\n**Members**: 5\n\n- Potassium-competitive acid blockers\n- ammonium chloride\n- potassium citrate\n- sodium bicarbonate\n- sodium bicarbonate solution gargling\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 91: Probiotic Supplementation\n\n**Category**: supplement\n**Members**: 5\n\n- Lactiplantibacillus plantarum and Bifidobacterium longum subspecies infantis synbiotic\n- Morinda officinalis oligosaccharides combined with probiotics\n- probiotic supplementation\n- probiotics\n- synbiotics\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 150: GLP-1RA and SGLT2i combination therapy\n\n**Category**: medication\n**Members**: 5\n\n- GLP-1RA and SGLT2i combination therapy\n- GLP-1RA monotherapy\n- SGLT2i and GLP-1RA combination therapy\n- SGLT2i and finerenone combination therapy\n- SGLT2i monotherapy\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 40: Retrograde Intrarenal Surgery\n\n**Category**: procedure\n**Members**: 4\n\n- Postural Drainage Lithotripsy (PDLS) combined with Retrograde Intrarenal Ureteral Lithotripsy (RIRS)\n- Retrograde Intrarenal Ureteral Lithotripsy (RIRS)\n- Retrograde intrarenal surgery (RIRS)\n- ureteral access sheath (UAS) use during RIRS\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 46: Platelet-rich plasma\n\n**Category**: supplement\n**Members**: 4\n\n- Platelet-rich plasma\n- autologous platelet-rich plasma\n- platelet-rich plasma injection\n- therapeutic plasma exchange\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 56: colloidal oatmeal-containing cream\n\n**Category**: medication\n**Members**: 4\n\n- 1% colloidal oatmeal-containing cream\n- benvitimod 1% cream\n- diclofenac 3% gel\n- tapinarof cream 1%\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 66: Baricitinib\n\n**Category**: medication\n**Members**: 4\n\n- Baricitinib\n- Tofacitinib\n- Upadacitinib\n- tofacitinib\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 97: JAK1/TYK2 Inhibitors\n\n**Category**: medication\n**Members**: 4\n\n- JAK1 inhibitors\n- Janus kinase inhibitors\n- PARP inhibitors\n- TYK2 inhibitors\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 112: Blue light phototherapy\n\n**Category**: procedure\n**Members**: 4\n\n- Benzoyl peroxide wash preparation\n- Blue light phototherapy\n- Combination of benzoyl peroxide wash and blue light phototherapy\n- transcranial photobiomodulation\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 118: Chinese Herbal Medicine (CHM)\n\n**Category**: supplement\n**Members**: 4\n\n- Chinese Herbal Medicine (CHM)\n- Meridian-Sinew Release Therapy combined with conventional Western medicine\n- acupuncture combined with herbal medicine\n- combination of traditional Chinese and Western medicine\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 30: OAC Regimen\n\n**Category**: medication\n**Members**: 3\n\n- OAC regimen\n- OAL regimen\n- OAMB regimen\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 39: Percutaneous Nephrolithotomy\n\n**Category**: procedure\n**Members**: 3\n\n- Percutaneous nephrolithotomy (PCNL)\n- minimally invasive percutaneous nephrolithotomy combined with ureteral access sheath\n- percutaneous nephrolithotomy\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 47: Ultrasound-Guided Strategy\n\n**Category**: procedure\n**Members**: 3\n\n- Lung and cardiac ultrasound (LuCUS)-guided strategy\n- low-intensity focused ultrasound\n- ultrasound\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 55: Acetyl-L-Carnitine\n\n**Category**: supplement\n**Members**: 3\n\n- Acetyl-L-Carnitine\n- Carnitine + Arginine + CoQ10\n- CoQ10\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 71: SSRIs\n\n**Category**: medication\n**Members**: 3\n\n- Benzodiazepines\n- SSRIs\n- duloxetine\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 79: Coronary artery bypass grafting (CABG)\n\n**Category**: surgery\n**Members**: 3\n\n- Coronary artery bypass grafting (CABG)\n- complete revascularization\n- coronary artery bypass grafting\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 84: omeprazole\n\n**Category**: medication\n**Members**: 3\n\n- Asvard capsule\n- omeprazole\n- omeprazole capsule\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 95: Mediterranean Diet Program\n\n**Category**: diet\n**Members**: 3\n\n- Mediterranean diet program\n- diet based on current dietary guidelines\n- modified Mediterranean diet\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 114: Orem's Self-Care Model Nursing\n\n**Category**: therapy\n**Members**: 3\n\n- Orem's self-care model nursing\n- nurse-led health literacy intervention\n- nurse-led person-centered self-management intervention\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 149: High-intensity interval training\n\n**Category**: exercise\n**Members**: 3\n\n- High-intensity interval training (HIIT)\n- high-intensity interval training\n- high-intensity interval training (HIIT)\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 151: GLP-1 Receptor Agonists\n\n**Category**: medication\n**Members**: 3\n\n- GLP-1 Receptor Agonists\n- GLP-1 receptor agonists\n- glucagon-like peptide-1 receptor agonists (GLP-1Ra)\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 0: Firsekibart\n\n**Category**: medication\n**Members**: 2\n\n- Firsekibart\n- firsekibart\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 1: BI 1595043\n\n**Category**: emerging\n**Members**: 2\n\n- BI 1595043\n- OTR-4131\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 2: Hepatocellular Carcinoma Surveillance Pathway\n\n**Category**: test\n**Members**: 2\n\n- HBV biomarkers-guided NAs withdrawal strategy\n- cirrhosis detection and hepatocellular carcinoma surveillance pathway\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 3: Imiquimod\n\n**Category**: medication\n**Members**: 2\n\n- Imiquimod\n- MCP-Mod\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 5: Cucumis sativus L. powder (Q-actinTM)\n\n**Category**: supplement\n**Members**: 2\n\n- Cucumis sativus L. powder (Q-actinTM)\n- Yiqi Chupi powder\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 10: NUT Combination with Monacolin K\n\n**Category**: supplement\n**Members**: 2\n\n- NUT combination containing Monacolin K (MK) alone\n- NUT combination containing Monacolin K (MK) and Morus alba\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Cluster 21: Incredible Years Parenting Programme\n\n**Category**: therapy\n**Members**: 2\n\n- Incredible Years (IY) parenting programme\n- Parents InC parenting programme\n\n**Quality Assessment**: [ ] GOOD / [ ] QUESTIONABLE / [ ] BAD\n**Notes**: \n\n--------------------------------------------------------------------------------\n\n## Remaining Clusters\n\nShowing top 30 of 100 total clusters. Remaining 70 clusters not shown (smaller clusters).\n\n